Image 3_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff

Image 3_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff

Background<p>Dynamic remodelling of the tumour microenvironment (TME) plays a central role in prostate cancer (PCa) progression, immune evasion and therapy resistance. However, the co-existence of both tumour-promoting and tumour-restraining stromal elements necessitates extensive characterisa...

Saved in:

书目详细资料
主要作者:	Elisabeth Damisch (22679276) (author)
其他作者:	Elena Brunner (11153976) (author), Lukas Nommensen (22679279) (author), Lucy Neumann (22679282) (author), Georgios Fotakis (9598167) (author), Zlatko Trajanoski (15774) (author), Sieghart Sopper (823900) (author), Georg Schäfer (279214) (author), Martin Puhr (697731) (author), Isabel Heidegger (689987) (author), Marianna Kruithof-de Julio (9014339) (author), Natalie Sampson (6414767) (author)
出版:	2025
主题:	Cell Biology cancer-associated fibroblast prostate cancer smooth muscle cell tissue dissociation single cell RNA sequencing tumour microenvironment
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

Image 5_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 8_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 4_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 6_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 2_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
由: Elisabeth Damisch (22679276)
出版: (2025)

Image 7_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tif
由: Elisabeth Damisch (22679276)
出版: (2025)

Table 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.xlsx
由: Elisabeth Damisch (22679276)
出版: (2025)

Data Sheet 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.docx
由: Elisabeth Damisch (22679276)
出版: (2025)

Data Sheet 1_Macrophage migration inhibitory factor–CD74 axis drives vascular smooth muscle cell–induced M1 macrophage polarization to exacerbate intracranial aneurysm inflammation.doc
由: Yao Chen (149006)
出版: (2025)

Supplementary file 1_Macrophage migration inhibitory factor–CD74 axis drives vascular smooth muscle cell–induced M1 macrophage polarization to exacerbate intracranial aneurysm inflammation.pdf
由: Yao Chen (149006)
出版: (2025)

Cross sections for dissociative recombination of ArH<sup>+</sup> and NeH<sup>+</sup> calculated using MQDT
由: Åsa Larson (22660418)
出版: (2025)

Supplementary Tables
由: Sushil Kumar (20371917)
出版: (2025)

Data Sheet 1_Fatty infiltration and cross-sectional area as indicators of muscle mass in osteoporosis: a meta-regression study.pdf
由: Genwen Sun (22678739)
出版: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
由: 辰宇石 (22420348)
出版: (2025)

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy
由: Thang Pham (19938126)
出版: (2025)

Supplemental figures for "Exercise enhances antioxidant protein levels in oxidative skeletal muscle via IL-1β"
由: Mami Yamada (1271472)
出版: (2025)

FGFs in CKD
由: Guillermo Gervasini (9650945)
出版: (2025)

Supplementary file 1_Effects of digital health interventions on muscle mass, muscle strength, and physical function in older adults with sarcopenia: a systematic review and meta-analysis.docx
由: Wenjia Chen (844791)
出版: (2025)

Table 3_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.docx
由: Huijie Deng (5664421)
出版: (2025)

Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif
由: Huijie Deng (5664421)
出版: (2025)

Image 1_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif
由: Huijie Deng (5664421)
出版: (2025)

Table 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.docx
由: Huijie Deng (5664421)
出版: (2025)

Table 1_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.docx
由: Huijie Deng (5664421)
出版: (2025)

Electrophysiological development and functional plasticity in dissociated human cerebral organoids across multiple cell lines - Raw MEA data (2 of 4)
由: Adam Pavlinek (20917388)
出版: (2025)

Electrophysiological development and functional plasticity in dissociated human cerebral organoids across multiple cell lines - Well average data and metadata (1 of 4)
由: Adam Pavlinek (20917388)
出版: (2025)

Image 2_Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation.tiff
由: Yini Wang (410389)
出版: (2025)

Image 1_Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation.tiff
由: Yini Wang (410389)
出版: (2025)

Supplementary Table 1 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
由: Sammy Ferri-Borgogno (15307295)
出版: (2025)

Supplementary Table 2 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
由: Sammy Ferri-Borgogno (15307295)
出版: (2025)

Supplementary Table 3 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
由: Sammy Ferri-Borgogno (15307295)
出版: (2025)

Supplementary Table 4 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
由: Sammy Ferri-Borgogno (15307295)
出版: (2025)

Figure 1 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
由: Angela Riedel (15130557)
出版: (2025)

Figure 2 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
由: Angela Riedel (15130557)
出版: (2025)

Figure 3 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
由: Angela Riedel (15130557)
出版: (2025)

Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
由: Angela Riedel (15130557)
出版: (2025)

Figure 5 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
由: Angela Riedel (15130557)
出版: (2025)

Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.
由: Seyed Reza Mousavi (13223324)
出版: (2025)

Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.
由: Seyed Reza Mousavi (13223324)
出版: (2025)

Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].
由: Seyed Reza Mousavi (13223324)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_75rv4l0aspbpuvlkt8q6e22nnu